CaboLu: A Phase 1b Study of Cabozantinib (cabo) in Combination with Lutetium (lu 177) Vipivotide Tetraxetan (LVT) in Patients (pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc).
JOURNAL OF CLINICAL ONCOLOGY(2024)
关键词
283-2494-5577-2829-12292,613-615-646-3281-7408-2399,283-2494-5577-2829-12292,130-3426,613-135-244-3829-325,298-145-222,261-566-148,171,38092-34892,38092-23249
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要